These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 16958947

  • 1. Combined cerebral blood flow effects of a cholinergic agonist (milameline) and a verbal recognition task in early Alzheimer's disease.
    Trollor JN, Sachdev PS, Haindl W, Brodaty H, Wen W, Walker BM.
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):616-25. PubMed ID: 16958947
    [Abstract] [Full Text] [Related]

  • 2. Detecting regional cerebral blood flow changes in Alzheimer's patients after milameline treatment: activation or baseline SPECT?
    Zheng XM.
    J Nucl Med Technol; 2002 Sep; 30(3):118-22. PubMed ID: 12186960
    [Abstract] [Full Text] [Related]

  • 3. Regional cerebral blood flow deficits in mild Alzheimer's disease using high resolution single photon emission computerized tomography.
    Trollor JN, Sachdev PS, Haindl W, Brodaty H, Wen W, Walker BM.
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):280-90. PubMed ID: 15896221
    [Abstract] [Full Text] [Related]

  • 4. Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers.
    Devous MD, Trivedi MH, Rush AJ.
    J Nucl Med; 2001 Apr; 42(4):535-42. PubMed ID: 11337538
    [Abstract] [Full Text] [Related]

  • 5. A high-resolution single photon emission computed tomography study of verbal recognition memory in Alzheimer's disease.
    Trollor JN, Sachdev PS, Haindl W, Brodaty H, Wen W, Walker BM.
    Dement Geriatr Cogn Disord; 2006 Apr; 21(4):267-74. PubMed ID: 16479105
    [Abstract] [Full Text] [Related]

  • 6. Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization.
    Schwarz RD, Callahan MJ, Coughenour LL, Dickerson MR, Kinsora JJ, Lipinski WJ, Raby CA, Spencer CJ, Tecle H.
    J Pharmacol Exp Ther; 1999 Nov; 291(2):812-22. PubMed ID: 10525104
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Imaging treatment effects in Alzheimer's disease.
    Venneri A.
    Magn Reson Imaging; 2007 Jul; 25(6):953-68. PubMed ID: 17446028
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Associations between cerebral blood-flow measured by single photon emission computed tomography (SPECT), electro-encephalogram (EEG), behaviour symptoms, cognition and neurological soft signs in children with attention-deficit hyperactivity disorder (ADHD).
    Gustafsson P, Thernlund G, Ryding E, Rosen I, Cederblad M.
    Acta Paediatr; 2000 Jul; 89(7):830-5. PubMed ID: 10943967
    [Abstract] [Full Text] [Related]

  • 12. Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.
    Bokde AL, Karmann M, Teipel SJ, Born C, Lieb M, Reiser MF, Möller HJ, Hampel H.
    J Clin Psychopharmacol; 2009 Apr; 29(2):147-56. PubMed ID: 19512976
    [Abstract] [Full Text] [Related]

  • 13. Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease.
    Soininen H, Helkala EL, Kuikka J, Hartikainen P, Lehtovirta M, Riekkinen PJ.
    J Neural Transm Park Dis Dement Sect; 1995 Apr; 9(2-3):95-109. PubMed ID: 8527009
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.
    Cader S, Palace J, Matthews PM.
    J Psychopharmacol; 2009 Aug; 23(6):686-96. PubMed ID: 18635705
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cholinergic enhancement increases regional cerebral blood flow to the posterior cingulate cortex in mild Alzheimer's disease.
    Iizuka T, Kameyama M.
    Geriatr Gerontol Int; 2017 Jun; 17(6):951-958. PubMed ID: 27215917
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task.
    Avery RA, Franowicz JS, Studholme C, van Dyck CH, Arnsten AF.
    Neuropsychopharmacology; 2000 Sep; 23(3):240-9. PubMed ID: 10942848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.